P

Inventor

LOGTENBERG TON

NL58 patents
⚠️ This page may combine multiple inventors who share the name “LOGTENBERG TON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERUS NV

27 patents
US9758805B2Sep 12, 2017

Methods and means for the production of Ig-like molecules

MERUS NV23 citations94
US10605808B2Mar 31, 2020

Antibody producing non-human animals

MERUS NV19 citations91
US9951124B2Apr 24, 2018

Antibody producing non-human mammals

MERUS NV10 citations91
US11279770B2Mar 22, 2022

Antibody that binds ErbB-2 and ErbB-3

MERUS NV7 citations85
US10752929B2Aug 25, 2020

Methods and means for the production of ig-like molecules

MERUS NV5 citations84
US10670599B2Jun 2, 2020

Method for selecting a single cell expressing a heterogeneous combination of antibodies

MERUS NV6 citations84
US10337045B2Jul 2, 2019

Methods and means for the production of Ig-like molecules

MERUS NV3 citations84
US10329596B2Jun 25, 2019

Methods and means for the production of Ig-like molecules

MERUS NV4 citations84
US11237165B2Feb 1, 2022

Antibody producing non-human animals

MERUS NV5 citations83
US10358492B2Jul 23, 2019

Bispecific IgG antibodies as T cell engagers

MERUS NV11 citations83
US10844127B2Nov 24, 2020

Antibodies that bind EGFR and ErbB3

MERUS NV8 citations82
US10647781B2May 12, 2020

Generation of binding molecules

MERUS NV6 citations82
US10934571B2Mar 2, 2021

Recombinant production of mixtures of antibodies

MERUS NV4 citations79
US12139548B2Nov 12, 2024

Antibody that binds ErbB-2 and ErbB-3

MERUS NV4 citations74
US12247078B2Mar 11, 2025

ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

MERUS NV3 citations73
US12123043B2Oct 22, 2024

Methods and means for the production of Ig-like molecules

MERUS NV1 citations73
US11926859B2Mar 12, 2024

Methods and means for the production of Ig-like molecules

MERUS NV2 citations73
US11780925B2Oct 10, 2023

ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

MERUS NV5 citations73
US11820825B2Nov 21, 2023

Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

MERUS NV2 citations71
US11753470B2Sep 12, 2023

Bispecific anti PD1-anti TIM3 antibodies

MERUS NV2 citations71
US11732043B2Aug 22, 2023

Antibodies that modulate a biological activity expressed by a cell

MERUS NV3 citations71
US11667714B2Jun 6, 2023

Binding molecules that modulate a biological activity expressed by a cell

MERUS NV3 citations71
US11408095B2Aug 9, 2022

Generation of binding molecules

MERUS NV2 citations71
US11559049B2Jan 24, 2023

Antibody producing non-human animals

MERUS NV2 citations70
US11939394B2Mar 26, 2024

Binding molecules that inhibit cancer growth

MERUS NV4 citations66
US11952424B2Apr 9, 2024

Multivalent antibody

MERUS NV1 citations62
US11785924B2Oct 17, 2023

Antibody producing non-human animals

MERUS NV0 citations62

MERUS B V

9 patents

CRUCELL HOLLAND BV

6 patents

LOGTENBERG TON

3 patents

MERUS BIOPHARMACEUTICALS B V I O

1 patent

BECTON DICKINSON CO

1 patent

VAN BERKEL PATRICIUS H C

1 patent

U BISYS BV

1 patent

HOOGENBOOM HENDRICUS RENERUS

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.